KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $57,679,000 | +73.4% | 320,779 | 0.0% | 0.02% | +69.2% |
| Q2 2017 | $33,255,000 | +15.8% | 320,779 | -12.3% | 0.01% | +8.3% |
| Q1 2017 | $28,707,000 | +70.4% | 365,745 | -2.7% | 0.01% | +71.4% |
| Q4 2016 | $16,848,000 | -16.0% | 375,745 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $20,047,000 | +24.0% | 375,745 | +16.2% | 0.01% | +12.5% |
| Q2 2016 | $16,168,000 | +16.5% | 323,365 | +7.0% | 0.01% | +14.3% |
| Q1 2016 | $13,873,000 | -30.3% | 302,169 | -6.4% | 0.01% | -30.0% |
| Q4 2015 | $19,900,000 | +33.3% | 322,946 | +20.4% | 0.01% | +25.0% |
| Q3 2015 | $14,930,000 | – | 268,146 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |